Cargando…
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
There is currently a worldwide epidemic of type 2 diabetes (T2D) that is predicted to increase substantially in the next few years. With 80% of the global T2D population living in low to middle-income countries, there are issues with cost and of access to appropriate medicines. The objective of this...
Autores principales: | Mohan, Viswanathan, Cooper, Mark E., Matthews, David R., Khunti, Kamlesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408564/ https://www.ncbi.nlm.nih.gov/pubmed/30758834 http://dx.doi.org/10.1007/s13300-019-0573-y |
Ejemplares similares
-
Introduction: Real-World Evidence in Type 2 Diabetes
por: Hassanein, Mohamed, et al.
Publicado: (2020) -
Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives
por: Khunti, Kamlesh, et al.
Publicado: (2020) -
Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program
por: Khunti, Kamlesh, et al.
Publicado: (2017) -
Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and
methods to overcome inertia
por: Khunti, Sachin, et al.
Publicado: (2019) -
Global accessibility of therapeutics for diabetes mellitus
por: Fralick, Michael, et al.
Publicado: (2022)